WITHDRAWN: Nucleic acid biomarkers of immune response and cell and tissue damage in COVID-19 and MIS-C

Conor Loy, Alicia Sotomayor-González, Venice Servellita, Jenny Nguyen, Joan Sesing Lenz, Sanchita Bhattacharya, Meagan E. Williams, Alexandre Pellan Cheng, Andrew Bliss, Prachi Saldhi, Noah Brazer, Jessica Streithorst, William Suslovic, Charlotte Hsieh, Burak Bahar, Nathan Wood, Abiodun Foresythe, Amelia S. Gliwa, Kushmita Bhakta, Maria A. Perez, Laila Hussaini, Evan J. Anderson, Ann Chahroudi, Meghan Delaney, Atul J. Butte, Roberta L. DeBiasi, Christina A. Rostad, Iwijn De Vlaminck, Charles Y. ChiumedRxiv 2022 · DOI

Note: This manuscript was withdrawn by the authors due to administrative consent issues; however, the findings were subsequently validated and published in Cell Reports Medicine. This summary reflects the scientific content of the original preprint.

Introduction

While most children experience mild symptoms from SARS-CoV-2 infection, a subset develops Multisystem Inflammatory Syndrome in Children (MIS-C), a severe and potentially life-threatening condition occurring weeks after the initial infection. Distinguishing MIS-C from acute COVID-19 or other inflammatory conditions like Kawasaki Disease remains a clinical challenge. This study utilizes multi-omic "liquid biopsy" techniques to identify specific nucleic acid biomarkers that characterize the unique immune signatures and tissue damage patterns of MIS-C.

Methods: A Multi-Analyte Approach

The researchers employed a comprehensive three-dimensional profiling of blood samples:

  1. Whole Blood RNA (wbRNA): Captures gene expression in circulating white blood cells to monitor the active host immune response.
  2. Plasma Cell-Free RNA (cfRNA): Analyzes transcripts released into the plasma, likely from dying cells. Using BayesPrism deconvolution against the Tabula Sapiens cell atlas, these transcripts were mapped back to specific tissues of origin.
  3. Plasma Cell-Free DNA (cfDNA): Employs whole-genome bisulfite sequencing to analyze DNA methylation patterns, providing a "tissue-of-origin" (TOO) profile to quantify DNA shed from specific organs like the heart, liver, or lungs.

Datasets and Cohort Overview

The study analyzed 416 blood samples from 237 pediatric patients across three major US hospital systems: UCSF, Emory University/Children’s Healthcare of Atlanta, and Children’s National Hospital.

Overview of the pediatric cohort, sample collection workflow, and disease severity classification for COVID-19 and MIS-C patients.

The cohort included 141 MIS-C patients, 70 acute COVID-19 patients, and 26 healthy controls. The researchers used the Tabula Sapiens human single-cell transcriptome atlas as a reference for their deconvolution algorithms.

Key Insights: Mapping the Damage

  • Complementary Profiling: wbRNA and cfRNA provide distinct perspectives; wbRNA tracks the immune "offensive," while cfRNA reveals the "collateral damage" to solid organs.
  • Unexpected Schwann Cell Involvement: A significant finding was the elevation of cfRNA from neuronal Schwann cells specifically in MIS-C, suggesting peripheral nervous system involvement.
  • T-Cell Exhaustion: Unlike the strong antiviral interferon response seen in acute COVID-19, MIS-C was characterized by the downregulation of T-cell pathways, suggesting a state of immune exhaustion.
  • Molecular Heterogeneity: MIS-C is characterized by highly variable damage across multiple organ systems (endothelium, liver, heart, kidney), reflecting its complex multisystem nature.

Key Results

The study identified several molecular hallmarks that differentiate MIS-C from acute COVID-19:

  • Elevated cfDNA Load: MIS-C patients showed significantly higher total cfDNA levels (mean 4.12 ng/uL) compared to other groups, indicating more extensive cell death.
  • Specific Biomarkers: The autoantigen TGM2 and endothelial markers like AKAP12 were significantly elevated in MIS-C cfRNA. Conversely, acute COVID-19 was dominated by interferon-stimulated genes such as ISG15 and RSAD2.
  • T-Cell Receptor Signatures: MIS-C showed a unique upregulation of TRBV11-2, a T-cell receptor segment previously linked to superantigen-like effects.
Comprehensive molecular profiling of MIS-C and COVID-19, showing cell type fractions, diversity indices, differential gene expression, and specific biomarkers.

Clinical Correlation and Limitations

Kidney-derived cfDNA concentrations correlated with clinical creatinine levels (R=0.40, p=0.004), validating the accuracy of these liquid biopsies in reflecting organ stress.

However, the study has limitations:

  • Withdrawal Status: The preprint was withdrawn due to consent issues, though findings were later validated.
  • Control Groups: The lack of a Kawasaki Disease control group limits the assessment of these biomarkers' specificity against similar inflammatory syndromes.
  • Reference Atlas Dependency: The resolution of tissue-of-origin profiling depends on the comprehensiveness of the underlying single-cell atlases.

This research demonstrates the power of multi-omic liquid biopsies to provide a detailed map of the systemic impact of SARS-CoV-2 in children, offering a path toward more precise diagnosis and monitoring of MIS-C.

Summary updated

Abstract

Withdrawal Statement The authors have withdrawn their manuscript owing to data from patients who had not been consented being inadvertently used in the preprint. This has been corrected in the version of the study published in Cell Reports Medicine. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.
BibTeX
@misc{loy2022withdrawn,
  author = {Conor Loy and Alicia Sotomayor-González and Venice Servellita and Jenny Nguyen and Joan Sesing Lenz and Sanchita Bhattacharya and Meagan E. Williams and Alexandre Pellan Cheng and Andrew Bliss and Prachi Saldhi and Noah Brazer and Jessica Streithorst and William Suslovic and Charlotte Hsieh and Burak Bahar and Nathan Wood and Abiodun Foresythe and Amelia S. Gliwa and Kushmita Bhakta and Maria A. Perez and Laila Hussaini and Evan J. Anderson and Ann Chahroudi and Meghan Delaney and Atul J. Butte and Roberta L. DeBiasi and Christina A. Rostad and Iwijn De Vlaminck and Charles Y. Chiu},
  title = {{WITHDRAWN: Nucleic acid biomarkers of immune response and cell and tissue damage in COVID-19 and MIS-C}},
  year = {2022},
  doi = {10.1101/2022.06.21.22276250},
  howpublished = {medRxiv},
}
Figure